Search Within

AUTOIMMUNE DISEASES

Tissular Senescence and Modifications of Oral Ecosystem in the Elderly: Risk Factors for Mucosal Pathologies

Journal: Current Aging Science
Volume: 2, Issue: 2
Page: 109-120
Authors: Agnes Bodineau, Marysette Folliguet and Sylvie Seguier

Sphingolipids in Cell Signaling: Their Function as Receptor Ligands, Second Messengers, and Raft Constituents

Journal: Current Immunology Reviews (Discontinued)
Volume: 2, Issue: 1
Page: 101-118
Authors: Thomas Baumruker and Andreas Billich

Autoantibodies Associated with Psychiatric Disorders

Journal: Current Neurovascular Research
Volume: 3, Issue: 2
Page: 149-157
Authors: Paola Margutti, Federica Delunardo and Elena Ortona

Human Parvovirus B19: An Infectious Agent with the Potential to Induce and Trigger Rheumatic Disease

Journal: Current Rheumatology Reviews
Volume: 2, Issue: 2
Page: 159-175
Authors: Hartwig W. Lehmann and Susanne Modrow

Comparative Genomics for the Investigation of Autoimmune Diseases

Journal: Current Pharmaceutical Design
Volume: 12, Issue: 29
Page: 3707-3722
Authors: Steffen Moller, Uwe K. Zettl, Pablo Serrano-Fernandez and Robert Goertsches

Nucleic Acids Modulate Autoimmunity Through Nucleic-Acid-Specific Toll-Like Receptors

Journal: Current Medicinal Chemistry
Volume: 13, Issue: 25
Page: 3061-3067
Authors:

NF-κB Inhibitors for the Treatment of Inflammatory Diseases and Cancer

Journal: Current Medicinal Chemistry
Volume: 14, Issue: 3
Page: 367-376
Authors: Marco A. Calzado, Susanne Bacher and M. Lienhard Schmitz

Pharmacological Targeting of IDO-Mediated Tolerance for Treating Autoimmune Disease

Journal: Current Drug Metabolism
Volume: 8, Issue: 3
Page: 245-266
Authors: W. T. Penberthy

The Role of Lymphotoxin Receptor Signaling in Diseases

Journal: Current Molecular Medicine
Volume: 7, Issue: 6
Page: 567-578
Authors: Alexei V. Tumanov, Peter A. Christiansen and Yang-Xin Fu

Advances in the Treatment of Autoimmune Diseases; Cellular Activity, Type-1/Type-2 Cytokine Secretion Patterns and their Modulation by Therapeutic Peptides

Journal: Current Medicinal Chemistry
Volume: 12, Issue: 13
Page: 1537-1550
Authors: Athanasia Mouzaki, Spyros Deraos and Kokona Chatzantoni

Endothelial Chemokines in Autoimmune Disease

Journal: Current Pharmaceutical Design
Volume: 10, Issue: 2
Page: 145-154
Authors: Kent W. Christopherson II and Robert A. Hromas

The NF-kB Pathway as a Potential Target for Autoimmune Disease Therapy

Journal: Current Pharmaceutical Design
Volume: 10, Issue: 23
Page: 2827-2837
Authors: Susanne Bacher and M. Lienhard Schmitz

The Impact of Fc Receptors on the Development of Autoimmune Diseases

Journal: Current Pharmaceutical Design
Volume: 9, Issue: 23
Page: 1861-1870
Authors: S. Kleinau

Autoimmune Lymphoproliferative Syndrome (ALPS)

Journal: Current Pharmaceutical Design
Volume: 9, Issue: 3
Page: 265-278
Authors: Jack J.H. Bleesing

Novel Molecular Targets for Systemic Lupus Erythematosus

Journal: Current Drug Targets
Volume: 3, Issue: 3
Page: 223-228
Authors: Maria Marino, Maria Rossi, Menotti Ruvo and Giorgio Fassina

The Ca2+-Activated K+ Channel of Intermediate Conductance:A Molecular Target for Novel Treatments?

Journal: Current Drug Targets
Volume: 2, Issue: 4
Page: 401-422
Authors: B. S. Jensen, D. Strobaek, S.-P. Olesen and P. Christophersen

Insights into the Pathogenesis of Type 1 Diabetes A Hint for Novel Immunospecific Therapies

Journal: Current Molecular Medicine
Volume: 1, Issue: 3
Page: 357-378
Authors: Sofia Casares and Teodor-Doru Brumeanu

Emerging Indications for Statins: A Pluripotent Family of Agents with Several Potential Applications

Journal: Current Pharmaceutical Design
Volume: 13, Issue: 35
Page: 3622-3636
Authors: Kosmas I. Paraskevas, Alexandros A. Tzovaras, Despina D. Briana and Dimitri P. Mikhailidis

Candidate Genes Implicated in Type 1 Diabetes Susceptibility

Journal: Current Diabetes Reviews
Volume: 4, Issue: 2
Page: 110-121
Authors: Mourad Aribi

Synthetic Glycolipid Ligands for Human iNKT Cells as Potential Therapeutic Agents for Immunotherapy

Journal: Current Medicinal Chemistry
Volume: 15, Issue: 23
Page: 2337-2345
Authors: Manabu Araki, Sachiko Miyake and Takashi Yamamura

The Antinflammatory Effect of Alpha-MSH in Skin: A Promise for New Treatment Strategies

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 8, Issue: 1
Page: 14-21
Authors: M. Auriemma, T. Luger, K. Loser, P. Amerio and A. Tulli

A New Drug Candidate (GEMSP) for Multiple Sclerosis

Journal: Current Medicinal Chemistry
Volume: 16, Issue: 25
Page: 3203-3214
Authors: Arturo Mangas, Rafael Covenas, Dominique Bodet, Sebastien Duleu and Michel Geffard

Functional Variants of the Interleukin-23 Receptor Gene in Non-Gastrointestinal Autoimmune Diseases

Journal: Current Medicinal Chemistry
Volume: 16, Issue: 28
Page: 3766-3774
Authors: E. Safrany and B. Melegh

Regulatory T Cells and Cancer Therapy: An Old Story with a New Hope

Journal: Current Cancer Therapy Reviews
Volume: 6, Issue: 1
Page: 34-40
Authors: Xinhai Zhang, Rick F. Thorne, Thomas E. Wagner and Yanzhang Wei

Hot topic: Editorial [Therapeutic Potential of Peptide Motifs - Part IV] (Jean Claude Herve)

Journal: Current Pharmaceutical Design
Volume: 16, Issue: 28
Page: 3053-3055
Authors: Jean-Claude Herve

Mechanisms of Altered Cell Immunity and Cytotoxicity in COPD

Journal: Current Drug Targets
Volume: 12, Issue: 4
Page: 450-459
Authors: M. Tsoumakidou, I. Tsiligianni and N. Tzanakis

B Cell Modulation Strategies in Autoimmunity: The SLE Example

Journal: Current Pharmaceutical Design
Volume: 17, Issue: 29
Page: 3155-3165
Authors: M. Manuela Rosado, Andrea Picchianti Diamanti, Federica Capolunghi and Rita Carsetti

Defective Autophagy in Fibroblasts May Contribute to Fibrogenesis in Autoimmune Processes

Journal: Current Pharmaceutical Design
Volume: 17, Issue: 35
Page: 3878-3887
Authors: Domenico Del Principe, Rosa Vona, Luciana Giordani, Elisabetta Straface and Anna Maria Giammarioli

Anti-TNF-α Antibody Therapies in Autoimmune Diseases

Journal: Current Topics in Medicinal Chemistry
Volume: 6, Issue: 16
Page: 1707-1714
Authors: Kokona Chatzantoni and Athanasia Mouzaki

Type I Interferon as a Target of Treatment in SLE

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 6, Issue: 4
Page: 323-330
Authors: P. Y. Lee and W. H. Reeves

Tolerance in the Absence of Autoantigen

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 7, Issue: 3
Page: 203-210
Authors: D. W. Pascual, J. Ochoa-Reparaz, A. Rynda and X. Yang

CD24 in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis: Targeting Redundancy for Immunotherapy?

Journal: Current Immunology Reviews (Discontinued)
Volume: 1, Issue: 2
Page: 173-176
Authors: Yang Liu, Xue-Feng Bai, Qunmin Zhou, Ou Li and Pan Zheng

The Impact of Infection on the Incidence of Autoimmune Disease

Journal: Current Topics in Medicinal Chemistry
Volume: 4, Issue: 5
Page: 521-529
Authors: T. David C. Thomas, Paola Zaccone, David W. Dunne and Anne Cooke

Modifying TNF alpha for Therapeutic Use A Perspective on the TNF Receptor System

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 1, Issue: 1
Page: 5-16
Authors: Akihiro Hasegawa, Watrau Takasaki, Mark I. Greene and Ramachandran Murali

Monoclonal Antibodies: New Therapeutic Agents for Autoimmune Hemolytic Anemia?

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 8, Issue: 1
Page: 62-68
Authors: Giovanni D'Arena, Ronald P. Taylor, Nicola Cascavilla and Margaret A. Lindorfer

Therapeutic Benefits of Regulating Inflammation in Autoimmunity

Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 7, Issue: 3
Page: 203-210
Authors: Enayat Nikoopour, Jordan Ari Schwartz and Bhagirath Singh

Tuning Immune Suppression in Systemic Autoimmunity with Self-Derived Peptides

Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 7, Issue: 4
Page: 253-259
Authors: Ram Pyare Singh, Bevra H. Hahn and Antonio La Cava

MICA Gene and Relevance to Immune Responses in Organ Transplants and Inflammatory, Tumoral and Autoimmune Diseases

Journal: Current Immunology Reviews (Discontinued)
Volume: 5, Issue: 2
Page: 122-134
Authors: Manuel Muro, Ruth Lopez-Hernandez, Jose Antonio Campillo, Daniel Lucas, Pedro Martinez-Garcia, Carmen Botella, Alfredo Minguela and Maria Rocio Alvarez-Lopez

Cot/Tpl-2 Protein Kinase as a Target for the Treatment of Inflammatory Disease

Journal: Current Topics in Medicinal Chemistry
Volume: 9, Issue: 7
Page: 611-622
Authors: D. George and A. Salmeron

The Expanding Role of TNF-Receptor Super Family Member CD40 (tnfrsf5) in Autoimmune Disease: Focus on Th40 Cells

Journal: Current Immunology Reviews (Discontinued)
Volume: 6, Issue: 2
Page: 130-136
Authors: Gisela Vaitaitis, Dan Waid and David H. Wagner Jr.

Systemic Sclerosis: Clinical Manifestations

Journal: Current Rheumatology Reviews
Volume: 6, Issue: 4
Page: 295-304
Authors: Jelena Blagojevic and Marco Matucci-Cerinic

Stem Cell-Based Therapies and Immunomodulatory Approaches in Newly Diagnosed Type 1 Diabetes

Journal: Current Stem Cell Research & Therapy
Volume: 6, Issue: 1
Page: 10-15
Authors: Carlos Eduardo Barra Couri and Julio Cesar Voltarelli

Pathogenesis of Graves Orbitopathy

Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Under Re-organization)
Volume: 11, Issue: 2
Page: 72-82
Authors: Mohd Shazli Draman and Marian Ludgate

Effects of Antioxidant Polyphenols on TNF-Alpha-Related Diseases

Journal: Current Topics in Medicinal Chemistry
Volume: 11, Issue: 14
Page: 1767-1779
Authors: Kiichiro Kawaguchi, Tsukasa Matsumoto and Yoshio Kumazawa

Dendritic Cells in Autoimmune Liver Diseases

Journal: Current Immunology Reviews (Discontinued)
Volume: 8, Issue: 1
Page: 23-27
Authors: Masanori Abe, Yoichi Hiasa and Morikazu Onji

Therapeutic Potential of Glycolipid Ligands for Natural Killer (NK) T Cells in the Suppression of Autoimmune Diseases

Journal: Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume: 5, Issue: 3
Page: 315-322
Authors: S. Miyake and T. Yamamura

From Cannabis to Endocannabinoids in Multiple Sclerosis: A Paradigm of Central Nervous System Autoimmune Diseases

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 4, Issue: 6
Page: 667-675
Authors: Anna M. Malfitano, Giuseppe Matarese and Maurizio Bifulco

Biological Therapies of Autoimmune Diseases

Journal: Current Drug Targets - Inflammation & Allergy
Volume: 4, Issue: 1
Page: 41-46
Authors: Irene S. Kourbeti and Dimitrios T. Boumpas

The TOLL-like / Type-I Interferon Pathways as Emerging Therapeutic Targets for Autoimmune Diseases

Journal: Drug Design Reviews - Online (Discontinued)
Volume: 1, Issue: 1
Page: 53-74
Authors: Patrick Englebienne

Mechanisms Leading to Autoantibody Production: Link Between Inflammation and Autoimmunity

Journal: Current Drug Targets - Inflammation & Allergy
Volume: 2, Issue: 3
Page: 232-241
Authors: Hitoshi Ohmori and Naoki Kanayama

New Therapies in SLE

Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 2, Issue: 1
Page: 11-23
Authors: Antonio La Cava, Francesca Ferrera, Gilberto Filaci, Marta Rizzi, Ram P. Singh, Francesco Indiveri and Bevra H. Hahn

CTLA-4Ig: Uses and Future Directions

Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 3, Issue: 2
Page: 132-142
Authors: Moshe Ben-Shoshan

Mouse Models of Autoimmune Diseases

Journal: Current Drug Discovery Technologies
Volume: 6, Issue: 4
Page: 262-269
Authors: Andreia Marques and Susen Muller

Alopecia Areata

Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 5, Issue: 2
Page: 98-107
Authors: Kam Lun E. Hon and Alexander K.C. Leung

Review of Recent Clinical Developments and Patents for the Treatment of Autoimmune and Inflammatory Diseases by Mesenchymal Stromal Cells

Journal: Recent Patents on Regenerative Medicine
Volume: 1, Issue: 3
Page: 228-248
Authors: Sowmya Viswanathan and Yoko Kosaka

Defining Peptide Sequences: From Antigenicity to Immunogenicity Through Redundancy

Journal: Current Pharmacogenomics
Volume: 4, Issue: 1
Page: 33-37
Authors: Darja Kanduc

Ablation of T-Helper 1 Cell Derived Cytokines and of Monocyte-Derived Tumor Necrosis Factor-α in Hereditary Hemorrhagic Telangiectasia: Immunological Consequences and Clinical Considerations

Journal: Current Pharmaceutical Design
Volume: 12, Issue: 10
Page: 1201-1208
Authors: F. Resta, V. Triggiani, E. Jirillo, C. Sabba, L. Amati and M. E. Passeri

Expression and Function of Cytokines and Chemokines in Neuropsychiatric Related Systemic Lupus Erythematosus

Journal: Current Rheumatology Reviews
Volume: 2, Issue: 2
Page: 177-185
Authors: Tsuyoshi Kasama, Takeo Isozaki, Tsuyoshi Odai, Mizuho Matsunawa and Nobuyuki Yajima

New Analytical Tools for Studying Autoimmune Diseases

Journal: Current Pharmaceutical Design
Volume: 12, Issue: 29
Page: 3735-3742
Authors: Matthias Kalbas, Angelika Lueking, Axel Kowald and Stefan Muellner

Development and Chemistry of Histamine H4 Receptor Ligands as Potential Modulators of Inflammatory and Allergic Responses

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 5, Issue: 4
Page: 307-322
Authors: J. D. Venable and R. L. Thurmond

Protein Kinase Inhibitors for the Treatment of Inflammation - An Overview

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 6, Issue: 1
Page: 3-4
Authors: Khusru Asadullah and Matthias Gaestel

B-Cell Based Gene Therapy for Inducing Tolerance

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 6, Issue: 2
Page: 141-150
Authors: Indira Carey, Yan Su, Yufei Jiang, Jonathan Skupsky and David W. Scott

Apoptosis: Potential Therapeutic Targets for New Drug Discovery

Journal: Current Medicinal Chemistry
Volume: 14, Issue: 22
Page: 2369-2379
Authors: Snehasis Jana and Jyoti Paliwal

Thalidomide as an Immunotherapeutic Agent: The Effects on Neutrophil- Mediated Inflammation

Journal: Current Pharmaceutical Design
Volume: 11, Issue: 3
Page: 395-401
Authors: Kozo Yasui, Norimoto Kobayashi, Takashi Yamazaki and Kazunaga Agematsu

Regulation of B Cell Activation by PECAM-1: Implications for the Development of Autoimmune Disorders

Journal: Current Pharmaceutical Design
Volume: 10, Issue: 2
Page: 155-161
Authors: Mae-Xhum Wong and Denise E. Jackson

The Role of STATs in Inflammation and Inflammatory Diseases

Journal: Current Pharmaceutical Design
Volume: 10, Issue: 23
Page: 2839-2850
Authors: E. Pfitzner, S. Kliem, D. Baus and M. C. Litterst

Regulation of the Immune Response by Natural IgM: Lessons from Warm Autoimmune Hemolytic Anemia

Journal: Current Pharmaceutical Design
Volume: 9, Issue: 23
Page: 1871-1880
Authors: Dorothea Stahl and Walter Sibrowski

Treatment of Refractory Autoimmune Diseases with Ablative Immunotherapy Using Monoclonal Antibodies and / or High Dose Chemotherapy with Hematopoietic Stem Cell Support

Journal: Current Pharmaceutical Design
Volume: 9, Issue: 3
Page: 279-288
Authors: Yossi Cohen, Aaron Polliack and Arnon Nagler

Inhibitors of AP-1 and NF-κB Mediated Transcriptional Activation: Therapeutic Potential in Autoimmune Diseases and Structural Diversity

Journal: Current Medicinal Chemistry
Volume: 9, Issue: 2
Page: 219-227
Authors: Moorthy s.s. Palanki

Modulation of Inducible Nitric Oxide Synthase Activation by Immuno-suppressive Drugs

Journal: Current Drug Metabolism
Volume: 2, Issue: 3
Page: 315-329
Authors: V. Trajkovic

Nucleic Acid Enzymes as a Novel Generation of Anti-gene Agents

Journal: Current Molecular Medicine
Volume: 1, Issue: 5
Page: 575-588
Authors: Mouldy Sioud

Antioxidant Therapy for Prevention of Inflammation, Ischemic Reperfusion Injuries and Allograft Rejection

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 6, Issue: 1
Page: 20-43
Authors: Huifang Chen, Anlun Ma and Shijie Qi

Treatment of Central Nervous System Involvement Associated with Primary Sjogrens Syndrome

Journal: Current Pharmaceutical Design
Volume: 14, Issue: 13
Page: 1270-1273
Authors: Salih Ozgocmen and Ali Gur

SAGE Application in Hematological Research

Journal: Current Pharmaceutical Biotechnology
Volume: 9, Issue: 5
Page: 383-391
Authors: Shin-ichi Hashimoto and Kouji Matsushima

Thrombotic Microangiopathies: Towards a Pathophysiology-Based Classification

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 9, Issue: 1
Page: 36-50
Authors: Paul Coppo and Agnes Veyradier

Gene Therapy Using IL-12 Family Members in Infection, Auto-Immunity, and Cancer

Journal: Current Gene Therapy
Volume: 9, Issue: 4
Page: 239-247
Authors: Maximilian J. Waldner and Markus F. Neurath

Polymorphisms in Methotrexate Pathways: What Is Clinically Relevant, What Is Not, and What Is Promising

Journal: Current Drug Metabolism
Volume: 10, Issue: 6
Page: 547-566
Authors: Guillermo Gervasini

Neuropeptide Receptors in Intestinal Disease: Physiology and Therapeutic Potential

Journal: Current Pharmaceutical Design
Volume: 16, Issue: 9
Page: 1091-1105
Authors: Susanne A. Snoek, Keren S. Borensztajn, Rene M. van den Wijngaard and Wouter J. de Jonge

Neuropeptides as Therapeutic Approach to Autoimmune Diseases

Journal: Current Pharmaceutical Design
Volume: 16, Issue: 28
Page: 3158-3172
Authors: Elena Gonzalez-Rey, Virginia Delgado-Maroto, Luciana Souza-Moreira and Mario Delgado

Molecular Field Analysis (MFA) and Other QSAR Techniques in Development of Phosphatase Inhibitors

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11, Issue: 1
Page: 151-163
Authors: Pramod C. Nair

Update on Intravenous Immunoglobulins (IVIg) Mechanisms of Action and Off- Label use in Autoimmune Diseases

Journal: Current Pharmaceutical Design
Volume: 17, Issue: 29
Page: 3166-3175
Authors: Uriel Katz, Yehuda Shoenfeld and Gisele Zandman-Goddard

mTOR Signaling and Metabolic Regulation of T Cells: New Potential Therapeutic Targets in Autoimmune Diseases

Journal: Current Pharmaceutical Design
Volume: 17, Issue: 35
Page: 3888-3897
Authors: Marina Pierdominici, Davide Vacirca, Federica Delunardo and Elena Ortona

Haematopoietic Stem Cell Gene Therapy to Treat Autoimmune Disease

Journal: Current Stem Cell Research & Therapy
Volume: 1, Issue: 3
Page: 279-287
Authors: Frank Alderuccio, Christopher Siatskas, James Chan, Judith Field, Kim Murphy, Zeyad Nasa and Ban-Hock Toh

Regulation of Protective and Pathogenic Th17 Responses

Journal: Current Immunology Reviews (Discontinued)
Volume: 3, Issue: 1
Page: 3-16
Authors: Gottfried Alber and Thomas Kamradt

B Cells and Beyond: Therapeutic Opportunities Targeting Inflammation

Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 6, Issue: 3
Page: 142-149
Authors: Bailin Liang, Ashlyn Eaton-Bassiri and Peter J. Bugelski

Anti-CCP Antibody Detection Facilitates Early Diagnosis and Prognosis of Rheumatoid Arthritis

Journal: Current Rheumatology Reviews
Volume: 1, Issue: 1
Page: 1-7
Authors: Ger J.M. Pruijn, Erik R. Vossenaar, Jan W. Drijfhout, Walther J. van Venrooij and Albert J.W. Zendman

NKT Cell-Stimulating Synthetic Glycolipids as Potential Therapeutics for Autoimmune Disease

Journal: Current Topics in Medicinal Chemistry
Volume: 4, Issue: 5
Page: 561-567
Authors: Takashi Yamamura, Katsuichi Miyamoto, Zsolt Illes, Endre Pal, Manabu Araki and Sachiko Miyake

Food Ingredients and Lipid Mediators

Journal: Current Nutrition & Food Science
Volume: 3, Issue: 4
Page: 255-276
Authors: Tzortzis Nomikos, Elizabeth Fragopoulou and Smaragdi Antonopoulou

Regulation of the PI3K-Akt Network: Current Status and a Promise for the Treatment of Human Diseases

Journal: Current Signal Transduction Therapy
Volume: 3, Issue: 2
Page: 138-151
Authors: Masayuki Noguchi, Toshiyuki Obata and Futoshi Suizu

Targeted Therapies – Many Ways to (the Peace of) Rome

Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Under Re-organization)
Volume: 8, Issue: 3
Page: 200-206
Authors: Martin Aringer and Josef S. Smolen

A Quantitative Structure-Activity Relationship Study on Some Series of Potassium Channel Blockers

Journal: Medicinal Chemistry
Volume: 5, Issue: 1
Page: 87-92
Authors: V. S.A. Kumar Satuluri, Jyostna Seelam and S. P. Gupta

Are B Cells a Potential Target for Therapeutic Intervention in the Classical T Cell-Mediated Autoimmune Disease Type 1 Diabetes?

Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 8, Issue: 2
Page: 130-138
Authors: Maja Wallberg and Elizabeth A. Green

Small Molecule Inhibitors of Phosphoinositide 3-Kinase (PI3K) δ and γ

Journal: Current Topics in Medicinal Chemistry
Volume: 9, Issue: 8
Page: 738-753
Authors: Michael K. Ameriks and Jennifer D. Venable

Invariant Natural Killer T Cell-Based Therapy of Autoimmune Diseases

Journal: Current Immunology Reviews (Discontinued)
Volume: 6, Issue: 2
Page: 88-101
Authors: Curtis L. Gabriel, Lan Wu, Vrajesh V. Parekh and Luc Van Kaer

Sex Hormones and their Analogues in Neuroimmune Biology

Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Under Re-organization)
Volume: 10, Issue: 3
Page: 142-181
Authors: Istvan Berczi, Reino Laatikainen and Juha Pulkkinen

Hematopoietic Stem Cell Transplantation for the Treatment of Autoimmunity in Type 1 Diabetes

Journal: Current Stem Cell Research & Therapy
Volume: 6, Issue: 1
Page: 29-37
Authors: Samuel A. LoCascio, Joia Spinelli and Josef Kurtz

B Cell Depletion with Rituximab in Graves Disease and Associated Orbitopathy

Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Under Re-organization)
Volume: 11, Issue: 2
Page: 99-111
Authors: Mario Salvi, Guia Vannucchi and Paolo Beck-Peccoz

Ubiquitin Ligases as Key Elements for the Modulation of the Immune Response: An Insight in the Pathogenesis of Autoimmunity

Journal: Current Rheumatology Reviews
Volume: 7, Issue: 3
Page: 246-252
Authors: Diana Gomez-Martin, Mariana Diaz Zamudio, Jorge Romo-Tena and Jorge Alcocer-Varela

Rituximab Therapy and Autoimmune Disease

Journal: Current Immunology Reviews (Discontinued)
Volume: 8, Issue: 1
Page: 94-100
Authors: Asha Ram Yadav and Nirmala Deo

TNF, Cell Death and Inflammation

Journal: Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume: 4, Issue: 6
Page: 557-567
Authors: Jacqueline Bixby, Tathagat D. Ray and Francis K.M. Chan